BlackRock’s RenovoRx RNXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9,162
Closed -$10.4K 5302
2024
Q2
$10.4K Sell
9,162
-11,678
-56% -$14.3K ﹤0.01% 5067
2024
Q1
$27.9K Sell
20,840
-548
-3% -$791 ﹤0.01% 4983
2023
Q4
$49K Buy
21,388
+6,054
+39% +$5.77K ﹤0.01% 4970
2023
Q3
$20.4K Buy
+15,334
New +$27.6K ﹤0.01% 5139
2022
Q2
Sell
-429
Closed -$1K 5959
2022
Q1
$1K Buy
+429
New +$1.5K ﹤0.01% 5790

Other funds holding RNXT

BlackRock's RNXT Position: Q3 2024 in Review

BlackRock sold out of RenovoRx (RNXT) in Q3 2024, closing a stake of 9,162 shares — an estimated $10.4K sold.

BlackRock first reported a position in RNXT in Q1 2022 and held it in 5 quarters. The position peaked at $49K in Q4 2023. 13 funds tracked by Wall St. Rank hold RNXT as of Q3 2024.

  • BlackRock reported no remaining RenovoRx position as of Q3 2024 after selling out during the quarter.
  • BlackRock sold 9,162 RenovoRx shares in Q3 2024, an estimated $10.4K.
  • BlackRock first reported a position in RenovoRx in Q1 2022 and held it in 5 quarters.
  • BlackRock's RenovoRx position peaked at $49K in Q4 2023.
  • 13 funds tracked by Wall St. Rank held RenovoRx as of Q3 2024.

Based on BlackRock's 13F filing for Q3 2024, filed 13 Nov 2024.